StonvexLoading…
StonvexCore line items from CMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $8.40B | $8.17B |
Operating Income | $949.00M | $1.13B |
Net Income | $680.00M | $850.00M |
EPS (Diluted) | $4.71 | $5.96 |
Total Assets | $34.45B | $32.53B |
Total Liabilities | $21.07B | $20.56B |
Cash & Equivalents | $2.61B | $1.53B |
Free Cash Flow OCF − CapEx | $120.00M | $-165.00M |
Shares Outstanding | 138.80M | 138.30M |